Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation

BACKGROUND: Extra-oesophageal reflux (EOR) may lead to microaspiration in patients with cystic fibrosis (CF), a probable cause of deteriorating lung function. Successful clinical trials of ivacaftor highlight opportunities to understand EOR in a real world study. METHODS: Data from 12 patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cyst Fibros
Autors principals: Zeybel, Gemma L., Pearson, Jeffrey P., Krishnan, Amaran, Bourke, Stephen J., Doe, Simon, Anderson, Alan, Faruqi, Shoaib, Morice, Alyn H., Jones, Rhys, McDonnell, Melissa, Zeybel, Mujdat, Dettmar, Peter W., Brodlie, Malcolm, Ward, Chris
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5264566/
https://ncbi.nlm.nih.gov/pubmed/27475719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2016.07.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars